Compare

Agentix Corp. vs Mosaic ImmunoEngineering Inc. vs Liminatus Pharma, Inc. vs Adaptin Bio, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Agentix Corp. AGTX	Mosaic ImmunoEngineering Inc. CPMV	Liminatus Pharma, Inc. LIMN	Adaptin Bio, Inc. APTN
Year ended	2026-03-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$485.6K	-$687.8K	-$10.21M	-$5.17M
EPS (Diluted)	-$0.01	-$0.10	-$0.43	-$0.66
Operating cash flow	-$108.5K	-$111.4K	-$9.96M	-$4.78M
Free cash flow	n/a	n/a	-$9.98M	n/a
Cash & equivalents	$771	$3.6K	n/a	$459.2K
Total assets	$771	$19.9K	$512.8K	$619.2K
Total liabilities	$3.60M	$7.50M	$10.33M	$2.11M
Shareholders' equity	-$3.60M	-$7.48M	-$9.81M	-$1.49M
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	40.07M	7.24M	27.06M	8.66M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Agentix Corp.	Mosaic ImmunoEngineering Inc.	Liminatus Pharma, Inc.	Adaptin Bio, Inc.
Latest	$0 Ended 2023-03-31	n/a	n/a	n/a
1 year earlier	$1.2K Ended 2022-03-31	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a